BERLIN (AP) — A German company working on a potential vaccine for the new coronavirus is denying reports that the U.S. government was angling to acquire it. In a tweet Monday, CureVac confirmed it had been one of the companies at a White House meeting earlier this month, but said the media reports about an offer were incorrect. The company says: “CureVac has not received from the U.S. government or related entities an offer before, during and since the task force meeting in the White House.” The reports on the alleged interest had caused tensions, with the economy minister saying that “Germany is not for sale.”